Precision BioSciences Inc (DTIL)
9.68
-0.14
(-1.43%)
USD |
NASDAQ |
Apr 25, 11:30
Precision BioSciences Total Long Term Debt (Quarterly): 22.41M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 22.41M |
September 30, 2023 | 22.36M |
June 30, 2023 | 22.32M |
March 31, 2023 | 22.27M |
December 31, 2022 | 22.22M |
September 30, 2022 | 22.17M |
June 30, 2022 | 22.12M |
March 31, 2022 | 2.482M |
December 31, 2021 | 2.478M |
September 30, 2021 | 2.454M |
June 30, 2021 | 2.431M |
March 31, 2021 | 0.00 |
Date | Value |
---|---|
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 52.44M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
22.41M
Maximum
Dec 2023
8.722M
Average
2.454M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
Altimmune Inc | 0.00 |
BioVie Inc | -- |
Adial Pharmaceuticals Inc | -- |
Gritstone Bio Inc | 40.14M |
Humacyte Inc | -- |